About Verisante
Verisante is a company based in Vancouver (Canada) founded in 2006. Verisante offers products and services including Reverse Takeover Service and Capital Raising Assistance. Verisante operates in a competitive market with competitors including Castle Biosciences, DermTech, DermaSensor, MedLumics and SciBase, among others.
- Headquarter Vancouver, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Verisante Technology, Inc.
-
Annual Revenue
Not available
-
Net Profit
-$79.77 K (USD)-26.78as on Dec 31, 2024
-
EBITDA
-$79.77 K (USD)15.78as on Dec 31, 2024
-
Latest Funding Round
$98.58 K (USD), Post-IPO
Jun 30, 2022
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Verisante
Verisante is a publicly listed company on the TSXV with ticker symbol VER.H in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Verisante
Verisante offers a comprehensive portfolio of products and services, including Reverse Takeover Service and Capital Raising Assistance.
Facilitates mergers for companies to go public quickly.
Helps businesses secure funding for growth initiatives.
Funding Insights of Verisante
Investments & Acquisitions by Verisante
Investment portfolio details for Verisante
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Verisante
Detailed financials for Verisante
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Verisante Comparisons
Peer comparison for Verisante
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Verisante
Verisante operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Castle Biosciences, DermTech, DermaSensor, MedLumics and SciBase, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| Locked | Locked | Locked |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| Locked | Locked | Locked |
Biological tissue imaging is developed using optical coherence tomography.
|
|
| Locked | Locked | Locked |
Point-of-care device for malignant melanoma detection is provided.
|
|
| Locked | Locked | Locked |
Prognostic tests for early-stage melanoma detection are developed.
|
Detailed competitors of Verisante
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Verisante
Complete news archive for Verisante
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Verisante
Verisante was founded in 2006 and raised its 1st funding round 7 years after it was founded.
Verisante is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Verisante is focused on the development and commercialization of diagnostic devices for early cancer detection. The companys products Verisante Aura allows skin cancer detection and the Verisante Core series is for lung, colon, and cervical cancer detection that utilizes a proprietary cancer detection platform while the operating software and probe technology are unique to each device. Verisante Aura is a non-invasive Raman spectroscopy system designed to detect skin cancer. The system provides information by identifying spectral changes associated with the biochemistry of skin cancer cells within seconds, hence, providing immediate results. The cancer detection platform was developed by the BC Cancer Agency and the University of British Columbia and tested and refined at the Skin Care Centre at Vancouver General Hospital.
Verisante's top competitors include DermTech, DermaSensor and AMLo Biosciences.
Verisante offers Reverse Takeover Service and Capital Raising Assistance.
Yes, Verisante is publicly traded on TSXV under the ticker symbol VER.H.
The ticker symbol of Verisante is VER.H on TSXV.